SIM
EDIT icon

Sonora Investment Management’s Editas Medicine EDIT Stock Holding History

Sonora Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-300
Closed -$9.95K – 1186
2018
Q1 		$9.95K Hold
300
– – ﹤0.01% 809
2017
Q4 		$9.22K Buy
+300
New +$7.55K ﹤0.01% 825

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sonora Investment Management's EDIT Position: Q2 2018 in Review

Sonora Investment Management sold out of Editas Medicine (EDIT) in Q2 2018, closing a stake of 300 shares — an estimated $9.95K sold.

Sonora Investment Management first reported a position in EDIT in Q4 2017 and held it in 2 quarters. The position peaked at $9.95K in Q1 2018. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2018.

  • Sonora Investment Management reported no remaining Editas Medicine position as of Q2 2018 after selling out during the quarter.
  • Sonora Investment Management sold 300 Editas Medicine shares in Q2 2018, an estimated $9.95K.
  • Sonora Investment Management first reported a position in Editas Medicine in Q4 2017 and held it in 2 quarters.
  • Sonora Investment Management's Editas Medicine position peaked at $9.95K in Q1 2018.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2018.

Based on Sonora Investment Management's 13F filing for Q2 2018, filed 6 Aug 2018.